Absence of tolerance to cataleptic activity of gammahydroxybutyrate after subchronic administration to male mice

Medical Science Research

Volumn 27, Issue 6, 1999, Pages 387-388

  Navarro, J F ^a   Pedraza, C ^b   Maldonado, E ^b   Cavas, M ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Campus de Teatinos   (Spain)

Author keywords

Catalepsy; Gamma hydroxybutyric acid

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0032806535     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vayer P, Mandel P, Maître M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 1987; 41:605-610.
2. Cash CD. Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994; 18:291-304.
3. Navarro JF, Pedraza C. An ethopharmacological assessment of the effects of gammahydroxybutyrate (GHB) on agonistic interactions in male mice. Med Sci Res 1996; 24:817-819.
4. Schmidt-Mutter C, Pan L. Sandner G, et al. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur J Pharmacol 1998; 342:21-27.
5. Lammers GJ, Arends J, Declerck AC, el al. Gamma-hydroxybutyrate and narcolepsy: A double-blind placebo-controlled study. Sleep 1993; 16:216-220.
6. Gallimberti L, Ferri M, Ferrara SD, et al. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double blind study. Alcohol Clin Exp Res 1992; 16:673-676.
7. Gallimberti L, Cibin M, Pagnin P, et al. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology 1993; 9:77-81.
8. Martellotta MC, Balducci C, Fattore L, et al. Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 1998; 59:697-702.
9. Martellotta MC, Fattore L, Cossu G, Fratta W. Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology 1997; 132:1-5.
10. Galloway GP, Frederick SL. Staggers FE Jr. et al. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92:89-96.
11. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB). A neuroactive drug with abuse potential. Clin Toxicol 1997; 35:581-590.
12. Hechler V, Gobaille S, Maitre M. Selective distribution pattern of gamma-hydroxybutyrate receptors in the brain. Brain Res 1992; 572:345-348.
13. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Pwgr Neurobiol 1997; 51:337-361.
14. Hechler V, Peter P, Gobaille S, et al. Gamma-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J Pharmacol Exp Ther 1993; 264:1406-1414.
15. Navarro JF, Martîn-Lopez M, Manzaneque JM, et al. Dose-dependent effect of gammahydroxybutyrate on catalepsy in mice. Med Sci Res 1996:24:603-604.
16. Navarro JF, Pedraza C, Martîn-Lopez M, et al. Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Pwgr Neuropsychopharmacol Biol Psychiat 1998; 22:835-844.